Is BioNTech Stock a Buy Now?
BioNTech (NASDAQ: BNTX) is the lesser-known member of the pair -- which also includes Pfizer -- that developed and marketed Comirnaty, one of the leading coronavirus vaccines on the market. However, it was originally BioNTech that created this clinical compound, which speaks highly to the biotech's innovative potential.
Still, like many other vaccine makers that made a fortune during the pandemic, with the passing of the state of emergency, BioNTech's stock has substantially underperformed the market this year. Should investors buy the dip on this biotech stock?
Source Fool.com
Pfizer Inc. Stock
€21.80
0.410%
With 15 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 29 € there is a positive potential of 33.06% for Pfizer Inc. compared to the current price of 21.8 €.
